Endothelial	0	11	B-Cell
cell	12	16	I-Cell
migration	17	26	O
and	27	30	O
vascular	31	39	B-Gene_or_gene_product
endothelial	40	51	I-Gene_or_gene_product
growth	52	58	I-Gene_or_gene_product
factor	59	65	I-Gene_or_gene_product
expression	66	76	O
are	77	80	O
the	81	84	O
result	85	91	O
of	92	94	O
loss	95	99	O
of	100	102	O
breast	103	109	B-Tissue
tissue	110	116	I-Tissue
polarity	117	125	O
.	125	126	O

Recruiting	128	138	O
a	139	140	O
new	141	144	O
blood	145	150	B-Organism_substance
supply	151	157	O
is	158	160	O
a	161	162	O
rate	163	167	O
-	167	168	O
limiting	168	176	O
step	177	181	O
in	182	184	O
tumor	185	190	B-Pathological_formation
progression	191	202	O
.	202	203	O

In	204	206	O
a	207	208	O
three	209	214	O
-	214	215	O
dimensional	215	226	O
model	227	232	O
of	233	235	O
breast	236	242	B-Organism_subdivision
carcinogenesis	243	257	O
,	257	258	O
disorganized	259	271	O
,	271	272	O
proliferative	273	286	O
transformed	287	298	O
breast	299	305	B-Cell
epithelial	306	316	I-Cell
cells	317	322	I-Cell
express	323	330	O
significantly	331	344	O
higher	345	351	O
expression	352	362	O
of	363	365	O
angiogenic	366	376	O
genes	377	382	O
compared	383	391	O
with	392	396	O
their	397	402	O
polarized	403	412	O
,	412	413	O
growth	414	420	O
-	420	421	O
arrested	421	429	O
nonmalignant	430	442	O
counterparts	443	455	O
.	455	456	O

Elevated	457	465	O
vascular	466	474	B-Gene_or_gene_product
endothelial	475	486	I-Gene_or_gene_product
growth	487	493	I-Gene_or_gene_product
factor	494	500	I-Gene_or_gene_product
(	501	502	O
VEGF	502	506	B-Gene_or_gene_product
)	506	507	O
secretion	508	517	O
by	518	520	O
malignant	521	530	B-Cell
cells	531	536	I-Cell
enhanced	537	545	O
recruitment	546	557	O
of	558	560	O
endothelial	561	572	B-Cell
cells	573	578	I-Cell
(	579	580	O
EC	580	582	B-Cell
)	582	583	O
in	584	586	O
heterotypic	587	598	O
cocultures	599	609	O
.	609	610	O

Significantly	611	624	O
,	624	625	O
phenotypic	626	636	O
reversion	637	646	O
of	647	649	O
malignant	650	659	B-Cell
cells	660	665	I-Cell
via	666	669	O
reexpression	670	682	O
of	683	685	O
HoxD10	686	692	B-Gene_or_gene_product
,	692	693	O
which	694	699	O
is	700	702	O
lost	703	707	O
in	708	710	O
malignant	711	720	O
progression	721	732	O
,	732	733	O
significantly	734	747	O
attenuated	748	758	O
VEGF	759	763	B-Gene_or_gene_product
expression	764	774	O
in	775	777	O
a	778	779	O
hypoxia	780	787	B-Gene_or_gene_product
-	787	788	I-Gene_or_gene_product
inducible	788	797	I-Gene_or_gene_product
factor	798	804	I-Gene_or_gene_product
1alpha	805	811	I-Gene_or_gene_product
-	811	812	O
independent	812	823	O
fashion	824	831	O
and	832	835	O
reduced	836	843	O
EC	844	846	B-Cell
migration	847	856	O
.	856	857	O

This	858	862	O
was	863	866	O
due	867	870	O
primarily	871	880	O
to	881	883	O
restoring	884	893	O
polarity	894	902	O
:	902	903	O
forced	904	910	O
proliferation	911	924	O
of	925	927	O
polarized	928	937	O
,	937	938	O
nonmalignant	939	951	B-Cell
cells	952	957	I-Cell
did	958	961	O
not	962	965	O
induce	966	972	O
VEGF	973	977	B-Gene_or_gene_product
expression	978	988	O
and	989	992	O
EC	993	995	B-Cell
recruitment	996	1007	O
,	1007	1008	O
whereas	1009	1016	O
disrupting	1017	1027	O
the	1028	1031	O
architecture	1032	1044	O
of	1045	1047	O
growth	1048	1054	O
-	1054	1055	O
arrested	1055	1063	O
,	1063	1064	O
reverted	1065	1073	O
cells	1074	1079	B-Cell
did	1080	1083	O
.	1083	1084	O

These	1085	1090	O
data	1091	1095	O
show	1096	1100	O
that	1101	1105	O
disrupting	1106	1116	O
cytostructure	1117	1130	B-Cellular_component
activates	1131	1140	O
the	1141	1144	O
angiogenic	1145	1155	O
switch	1156	1162	O
even	1163	1167	O
in	1168	1170	O
the	1171	1174	O
absence	1175	1182	O
of	1183	1185	O
proliferation	1186	1199	O
and	1200	1203	O
/	1203	1204	O
or	1204	1206	O
hypoxia	1207	1214	O
and	1215	1218	O
restoring	1219	1228	O
organization	1229	1241	O
of	1242	1244	O
malignant	1245	1254	O
clusters	1255	1263	O
reduces	1264	1271	O
VEGF	1272	1276	B-Gene_or_gene_product
expression	1277	1287	O
and	1288	1291	O
EC	1292	1294	B-Cell
activation	1295	1305	O
to	1306	1308	O
levels	1309	1315	O
found	1316	1321	O
in	1322	1324	O
quiescent	1325	1334	O
nonmalignant	1335	1347	O
epithelium	1348	1358	B-Tissue
.	1358	1359	O

These	1360	1365	O
data	1366	1370	O
confirm	1371	1378	O
the	1379	1382	O
importance	1383	1393	O
of	1394	1396	O
tissue	1397	1403	B-Tissue
architecture	1404	1416	O
and	1417	1420	O
polarity	1421	1429	O
in	1430	1432	O
malignant	1433	1442	B-Pathological_formation
progression	1443	1454	O
.	1454	1455	O

